Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens

Frontiers in Microbiology

Volumn 6, Issue JUN, 2015, Pages

  Tiwari, Vishvanath ^a   Roy, Ranita ^a   Tiwari, Monalisa ^a  

^a CENTRAL UNIVERSITY OF RAJASTHAN   (India)

Author keywords

Acinetobacter baumannii; Antibacterial activity; Carbapenem resistance; Herbal medicine; Mic

Indexed keywords

CARBAPENEM; HERBACEOUS AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANALYTIC METHOD; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CELL DIVISION; COLONY FORMING UNIT; COMPUTER MODEL; DISK DIFFUSION; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS);

EID: 84936996797     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00618     Document Type: Article

References (100)

1. Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., and Carmeli, Y. (2005). Multidrug-resistant Acinetobacter baumannii. Emerg. Infect. Dis. 11, 22-29. doi: 10.3201/eid1101.040001
2. Acosta, J., Merino, M., Viedma, E., Poza, M., Sanz, F., Otero, J. R., et al (2011). Multidrug-resistant Acinetobacter baumannii Harboring OXA-24 carbapenemase, Spain. Emerg. Infect. Dis. 17, 1064-1067. doi: 10.3201/eid/1706.091866
3. Afzal-Shah, M., Woodford, N., and Livermore, D. M. (2001). Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45, 583-588. doi: 10.1128/AAC.45.2.583-588.2001
4. Alsultan, A. A., Hamouda, A., Evans, B. A., and Amyes, S. G. (2009). Acinetobacter baumannii: emergence of four strains with novel bla(OXA-51-like) genes in patients with diabetes mellitus. J. Chemother. 21, 290-295. doi: 10.1179/joc.2009.21.3.290
5. Anstey, N. M., Currie, B. J., Hassell, M., Palmer, D., Dwyer, B., and Seifert, H. (2002). Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J. Clin. Microbiol. 40, 685-686. doi: 10.1128/JCM.40.2.685-686.2002
6. Anstey, N. M., Currie, B. J., and Withnall, K. M. (1992). Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin. Infect. Dis. 14, 83-91. doi: 10.1093/clinids/14.1.83
7. Becker, H., Scher, J. M., Speakman, J. B., and Zapp, J. (2005). Bioactivity guided isolation of antimicrobial compounds from Lythrum salicaria. Fitoterapia 76, 580-584. doi: 10.1016/j.fitote.2005.04.011
8. Betts, J. W., Kelly, S. M., and Haswell, S. J. (2011). Antibacterial effects of theaflavin and synergy with epicatechin against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. Int. J. Antimicrob. Agents 38, 421-425. doi: 10.1016/j.ijantimicag.2011.07.006
9. Betts, J. W., and Wareham, D. W. (2014). In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii. BMC Microbiol. 14:172. doi: 10.1186/1471-2180-14-172
10. Brown, S., Young, H. K., and Amyes, S. G. (2005). Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect. 11, 15-23. doi: 10.1111/j.1469-0691.2004.01016.x
11. Burt, S. (2004). Essential oils: their antibacterial properties and potential applications in foods-a review. Int. J. Food Microbiol. 94, 223-253. doi: 10.1016/j.ijfoodmicro.2004.03.022
12. Cefai, C., Richards, J., Gould, F. K., and Mcpeake, P. (1990). An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J. Hosp. Infect. 15, 177-182. doi: 10.1016/0195-6701(90)90128-B
13. Chan, B. C.-L., Lau, C. B.-S., Jolivalt, C., Lui, S.-L., Ganem-Elbaz, C., Paris, J.-M., et al (2011). "Chinese medicinal herbs against antibiotic-resistant bacterial pathogens," in Science Against Microbial Pathogens: Communicating Current Research and Technological Advances, Vol. 2, ed A. Méndez-Vilas (Extremadura: Formatex). 773-781.
14. Chan, P. C., Huang, L. M., Lin, H. C., Chang, L. Y., Chen, M. L., Lu, C. Y., et al (2007). Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 28, 423-429. doi: 10.1086/513120
15. Chaulagain, B. P., Jang, S. J., Ahn, G. Y., Ryu, S. Y., Kim, D. M., Park, G., et al (2012). Molecular epidemiology of an outbreak of imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla(OXA-51-like) genes in a Korean hospital. Jpn. J. Infect. Dis. 65, 162-166.
16. Chuang, Y. C., Chang, S. C., and Wang, W. K. (2010). High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy. PLoS ONE 5:e14133. doi: 10.1371/journal.pone.0014133
17. Chusri, S., Villanueva, I., Voravuthikunchai, S. P., and Davies, J. (2009). Enhancing antibiotic activity: a strategy to control Acinetobacter infections. J. Antimicrob. Chemother. 64, 1203-1211. doi: 10.1093/jac/dkp381
18. Culebras, E., Gonzalez-Romo, F., Head, J., Gomez, M., Morales, G., and Picazo, J. J. (2010). Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: epidemiology and study of patient movements. Microb. Drug Resist. 16, 309-315. doi: 10.1089/mdr.2009.0113
19. Cunha, B. A., Klimek, J. J., Gracewski, J., Mclaughlin, J. C., and Quintiliani, R. (1980). A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers. Postgrad. Med. J. 56, 169-172. doi: 10.1136/pgmj.56.653.169
20. Daffre, S., Bulet, P., Spisni, A., Ehret-Sabatier, L., Rodrigues, E., and Travassos, L. R. (2008). Bioactive natural peptides. Stud. Nat. Prod. Chem. 35, 597-691. doi: 10.1016/S1572-5995(08)80015-4
21. Dalla-Costa, L. M., Coelho, J. M., Souza, H. A., Castro, M. E., Stier, C. J., Bragagnolo, K. L., et al (2003). Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol. 41, 3403-3406. doi: 10.1128/JCM.41.7.3403-3406.2003
22. De, R., Kundu, P., Swarnakar, S., Ramamurthy, T., Chowdhury, A., Nair, G. B., et al (2009). Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 53, 1592-1597. doi: 10.1128/AAC.01242-08
23. Djeussi, D. E., Noumedem, J. A., Seukep, J. A., Fankam, A. G., Voukeng, I. K., Tankeo, S. B., et al (2013). Antibacterial activities of selected edible plants extracts against multidrug-resistant Gram-negative bacteria. BMC Complement. Altern. Med. 13:164. doi: 10.1186/1472-6882-13-164
24. Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., and Griffin, J. L. (2011). Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev. 40, 387-426. doi: 10.1039/B906712B
25. Dunn, W. B., and Ellis, D. I. (2005). Metabolomics: current analytical platforms and methodologies. Trends Anal. Chem. 24, 285-294. doi: 10.1016/j.trac.2004.11.021
26. Endo, S., Yano, H., Hirakata, Y., Arai, K., Kanamori, H., Ogawa, M., et al (2012). Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan. J. Antimicrob. Chemother. 67, 1623-1626. doi: 10.1093/jac/dks094
27. Ettefagh, K. A., Burns, J. T., Junio, H. A., Kaatz, G. W., and Cech, N. B. (2011). Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition. Planta Med. 77, 835-840. doi: 10.1055/s-0030-1250606
28. Fabry, W., Okemo, P. O., and Ansorg, R. (1998). Antibacterial activity of East African medicinal plants. J. Ethnopharmacol. 60, 79-84. doi: 10.1016/S0378-8741(97)00128-1
29. Fernandez-Cuenca, F., Martinez-Martinez, L., Conejo, M. C., Ayala, J. A., Perea, E. J., and Pascual, A. (2003). Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51, 565-574. doi: 10.1093/jac/dkg097
30. Formisano, C., Rigano, D., Senatore, F., Raimondo, F. M., Maggio, A., and Bruno, M. (2012). Essential oil composition and antibacterial activity of Anthemis mixta and A. tomentosa (Asteraceae). Nat. Prod. Commun. 7, 1379-1382.
31. Gales, A. C., Tognim, M. C., Reis, A. O., Jones, R. N., and Sader, H. S. (2003). Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn. Microbiol. Infect. Dis. 45, 77-79. doi: 10.1016/S0732-8893(02)00500-X
32. Gill, A. O., and Holley, R. A. (2006). Disruption of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics. Int. J. Food Microbiol. 108, 1-9. doi: 10.1016/j.ijfoodmicro.2005.10.009
33. Gordon, N. C., and Wareham, D. W. (2010). Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia. Int. J. Antimicrob. Agents 36, 129-131. doi: 10.1016/j.ijantimicag.2010.03.025
34. Guclu, E., Genc, H., Zengin, M., and Karabay, O. (2014). Antibacterial activity of Lythrum salicaria against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Annu. Res. Rev. Biol. 4, 1099-1105. doi: 10.9734/ARRB/2014/7357
35. Hagel, J. M., and Facchini, P. J. (2008). Plant metabolomics: analytical platforms and integration with functional genomics. Phytochem. Rev. 7, 479-497. doi: 10.1007/s11101-007-9086-9
36. Horrevorts, A., Bergman, K., Kollee, L., Breuker, I., Tjernberg, I., and Dijkshoorn, L. (1995). Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33, 1567-1572.
37. Hu, P., Huang, P., and Chen, M. W. (2013). Curcumin reduces Streptococcus mutans biofilm formation by inhibiting sortase A activity. Arch. Oral Biol. 58, 1343-1348. doi: 10.1016/j.archoralbio.2013.05.004
38. Hu, W. S., Yao, S. M., Fung, C. P., Hsieh, Y. P., Liu, C. P., and Lin, J. F. (2007). An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 3844-3852. doi: 10.1128/AAC.01512-06
39. Huang, H. C., Wang, H. F., Yih, K. H., Chang, L. Z., and Chang, T. M. (2012). Dual bioactivities of essential oil extracted from the leaves of Artemisia argyi as an antimelanogenic versus antioxidant agent and chemical composition analysis by GC/MS. Int. J. Mol. Sci. 13, 14679-14697. doi: 10.3390/ijms131114679
40. Iredell, J., Thomas, L., Power, D., and Mendes, E. (2007). Tigecycline resistance in Australian antibiotic-resistant Gram-negative bacteria. J. Antimicrob. Chemother. 59, 816-818. doi: 10.1093/jac/dkm002
41. Jacobo-Salcedo Mdel, R., Gonzalez-Espindola, L. A., Alonso-Castro, A. J., Gonzalez-Martinez Mdel, R., Dominguez, F., and Garcia-Carranca, A. (2011). Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds. Nat. Prod. Commun. 6, 1121-1124.
42. Jeon, B. C., Jeong, S. H., Bae, I. K., Kwon, S. B., Lee, K., Young, D., et al (2005). Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in Korea. J. Clin. Microbiol. 43, 2241-2245. doi: 10.1128/JCM.43.5.2241-2245.2005
43. Jeong, S. H., Bae, I. K., Park, K. O., An, Y. J., Sohn, S. G., Jang, S. J., et al (2006). Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J. Microbiol. 44, 423-431.
44. Khadri, S., Boutefnouchet, N., and Dekhil, M. (2010). Antibacterial activity evaluation of Allium sativum essential oil compared to different Pseudomonas aeruginosa strains in Eastern algeria. Sci. Stud. Res. Chem. Chem. Eng. Biotechnol. Food Ind. 11, 421-428.
45. Kono, K., Tatara, I., Takeda, S., Arakawa, K., Shirotani, T., Okada, M., et al (1997). Antibacterial activity of epigallocatechin gallate against Helicobacter pylori: synergistic effect with Plaunotol. J. Infect. Chemother. 3, 170-172. doi: 10.1007/BF02491509
46. Ko, K. S., Suh, J. Y., Kwon, K. T., Jung, S. I., Park, K. H., Kang, C. I., et al (2007). High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 60, 1163-1167. doi: 10.1093/jac/dkm305
47. Koh, T. H., Sng, L. H., Wang, G. C., Hsu, L. Y., and Zhao, Y. (2007). IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J. Antimicrob. Chemother. 59, 627-632. doi: 10.1093/jac/dkl544
48. Kollanoor Johny, A., Darre, M. J., Donoghue, A. M., Donoghue, D. J., and Venkitanarayanan, K. (2010). Antibacterial effect of trans-cinnamaldehyde, eugenol, carvacrol, and thymol on Salmonella enteritidis and Campylobacter jejuni in chicken cecal contents in vitro. J. Appl. Poult. Res. 19, 237-244. doi: 10.3382/japr.2010-00181
49. Lawrence, R., Tripathi, P., and Jeyakumar, E. (2009). Isolation, purification and evaluation of antibacterial agents from aloe vera. Braz. J. Microbiol. 40, 906-915. doi: 10.1590/S1517-83822009000400023
50. Lewis, K., and Ausubel, F. M. (2006). Prospects for plant-derived antibacterials. Nat. Biotechnol. 24, 1504-1507. doi: 10.1038/nbt1206-1504
51. Lin, W. R., Lu, P. L., Siu, L. K., Chen, T. C., Lin, C. Y., Hung, C. T., et al (2011). Rapid control of a hospital-wide outbreak caused by extensively drug-resistant OXA-72-producing Acinetobacter baumannii. Kaohsiung J. Med. Sci. 27, 207-214. doi: 10.1016/j.kjms.2010.11.004
52. Lu, X., Rasco, B. A., Jabal, J. M., Aston, D. E., Lin, M., and Konkel, M. E. (2011). Investigating antibacterial effects of garlic (Allium sativum) concentrate and garlic-derived organosulfur compounds on Campylobacter jejuni by using Fourier transform infrared spectroscopy, Raman spectroscopy, and electron microscopy. Appl. Environ. Microbiol. 77, 5257-5269. doi: 10.1128/AEM.02845-10
53. Lv, F., and Xu, X. J. (2008). Studies on the chemical constituents of Rabdosia rubescens. Zhong Yao Cai 31, 1340-1343.
54. Manchanda, V., Sanchaita, S., and Singh, N. (2010). Multidrug resistant acinetobacter. J. Glob. Infect. Dis. 2, 291-304. doi: 10.4103/0974-777X.68538
55. Marchaim, D., Navon-Venezia, S., Leavitt, A., Chmelnitsky, I., Schwaber, M. J., and Carmeli, Y. (2007). Molecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital. Infect. Control Hosp. Epidemiol. 28, 945-950. doi: 10.1086/518970
56. Masoud, E. A., and Gouda, H. A. (2012). Effect of some natural plant extracts against gram negative bacteria in Njran Area, Saudi Arabia. Egypt. Acad. J. Biolog. Sci. 4, 85-92.
57. Mendes, R. E., Farrell, D. J., Sader, H. S., and Jones, R. N. (2010). Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009). Diagn. Microbiol. Infect. Dis. 68, 307-311. doi: 10.1016/j.diagmicrobio.2010.07.003
58. Merkier, A. K., and Centron, D. (2006). bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int. J. Antimicrob. Agents 28, 110-113. doi: 10.1016/j.ijantimicag.2006.03.023
59. Miyasaki, Y., Rabenstein, J. D., Rhea, J., Crouch, M. L., Mocek, U. M., Kittell, P. E., et al (2013). Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii. PLoS ONE 8:e61594. doi: 10.1371/journal.pone.0061594
60. Mun, S. H., Joung, D. K., Kim, Y. S., Kang, O. H., Kim, S. B., Seo, Y. S., et al (2013). Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine 20, 714-718. doi: 10.1016/j.phymed.2013.02.006
61. Nand, P., Drabu, S., and Rk, G. (2012). Insignificant anti-acne activity of Azadirachta indica leaves and bark. J. Pharm. Negat. Results 3, 29-33. doi: 10.4103/0976-9234.99650
62. Nostro, A., Sudano Roccaro, A., Bisignano, G., Marino, A., Cannatelli, M. A., Pizzimenti, F. C., et al (2007). Effects of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Med. Microbiol. 56, 519-523. doi: 10.1099/jmm.0.46804-0
63. Oleszek, W., and Marston, A. (eds.) (2000). "Saponins in food, feedstuffs and medicinal plants," in Proceedings of the Phytochemical Society of Europe, Vol. 45, 1-95. Available online at: http://www.springer.com/in/book/9780792360230
64. Osterburg, A., Gardner, J., Hyon, S. H., Neely, A., and Babcock, G. (2009). Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG). Clin. Microbiol. Infect. 15, 341-346. doi: 10.1111/j.1469-0691.2009.02710.x
65. Oteo, J., Garcia-Estebanez, C., Miguelanez, S., Campos, J., Marti, S., Vila, J., et al (2007). Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain. J. Infect. 55, 260-266. doi: 10.1016/j.jinf.2007.04.009
66. Pacôme, O. A., Bernard, D. N., Sékou, D., Joseph, D. A., David, N. G. J., Mongomaké, K., et al (2014). Phytochemical and antioxidant activity of Roselle (Hibiscus Sabdariffa L.) petal extracts. Res. J. Pharm. Biol. Chem. Sci. 5, 1453-1465.
67. Peleg, A. Y., Franklin, C., Bell, J. M., and Spelman, D. W. (2006). Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia. Infect. Control Hosp. Epidemiol. 27, 759-761. doi: 10.1086/507012
68. Pelletier, R. P. (2012). Effect of Plant-Derived Molecules on Acinetobacter baumannii Biofilm on Abiotic Surfaces. Honors Scholar Theses, University of Connecticut, Storrs.
69. Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., and Bonomo, R. A. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 3471-3484. doi: 10.1128/AAC.01464-06
70. Phillipson, J. D. (2007). Phytochemistry and pharmacognosy. Phytochemistry 68, 2960-2972. doi: 10.1016/j.phytochem.2007.06.028
71. Playford, E. G., Craig, J. C., and Iredell, J. R. (2007). Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J. Hosp. Infect. 65, 204-211. doi: 10.1016/j.jhin.2006.11.010
72. Rai, D., Singh, J. K., Roy, N., and Panda, D. (2008). Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem. J. 410, 147-155. doi: 10.1042/BJ20070891
73. Rice, L. B. (2006). Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin. Infect. Dis. 43(Suppl. 2), S100-S105. doi: 10.1086/504487
74. Riley, T. V., Webb, S. A., Cadwallader, H., Briggs, B. D., Christiansen, L., and Bowman, R. A. (1996). Outbreak of gentamicin-resistant Acinetobacter baumanii in an intensive care unit: clinical, epidemiological and microbiological features. Pathology 28, 359-363. doi: 10.1080/00313029600169354
75. Rodriguez-Martinez, J. M., Poirel, L., and Nordmann, P. (2010). Genetic and functional variability of AmpC-type beta-lactamases from Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 4930-4933. doi: 10.1128/AAC.00427-10
76. Sader, H. S., Castanheira, M., Mendes, R. E., Toleman, M., Walsh, T. R., and Jones, R. N. (2005). Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrob. Agents 25, 57-61. doi: 10.1016/j.ijantimicag.2004.08.013
77. Santella, G., Docquier, J. D., Gutkind, G., Rossolini, G. M., and Radice, M. (2011). Purification and biochemical characterization of IMP-13 metallo-beta-lactamase. Antimicrob. Agents Chemother. 55, 399-401. doi: 10.1128/AAC.00421-10
78. Saulnier, P. M. A. (2014). Aromatic and terpenic compounds loaded in lipidic nanocapsules: activity against multi-drug resistant Acinetobacter baumannii assessed in vitro and in a murine model of sepsis. J. Nanomed. Nanotechnol. 5:206. doi: 10.4172/2157-7439.1000206
79. Savoia, D. (2012). Plant-derived antimicrobial compounds: alternatives to antibiotics. Future Microbiol. 7, 979-990. doi: 10.2217/fmb.12.68
80. Shahcheraghi, F., Abbasalipour, M., Feizabadi, M., Ebrahimipour, G., and Akbari, N. (2011). Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran. J. Microbiol. 3, 68-74.
81. Sherertz, R. J., and Sullivan, M. L. (1985). An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients' mattresses. J. Infect. Dis. 151, 252-258. doi: 10.1093/infdis/151.2.252
82. Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., and Lewis, K. (2000). Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. U.S.A. 97, 1433-1437. doi: 10.1073/pnas.030540597
83. Tiwari, V., Kapil, A., and Moganty, R. R. (2012). Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. Microb. Pathog. 53, 81-86. doi: 10.1016/j.micpath.2012.05.004
84. Tiwari, V., and Moganty, R. R. (2013). Structural studies on New Delhi Metallo-beta-lactamase (NDM-2) suggest old beta-lactam, penicillin to be better antibiotic for NDM-2-harbouring Acinetobacter baumanni. J. Biomol. Struct. Dyn. 31, 591-601. doi: 10.1080/07391102.2012.706075
85. Tiwari, V., and Moganty, R. R. (2014). Conformational stability of OXA-51 beta-lactamase explains its role in carbapenem resistance of Acinetobacter baumannii. J. Biomol. Struct. Dyn. 32, 1406-1420. doi: 10.1080/07391102.2013.819789
86. Tiwari, V., and Tiwari, M. (2014). Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii. Front. Microbiol. 5:512. doi: 10.3389/fmicb.2014.00512
87. Tiwari, V., and Tiwari, M. (2015). Phosphoproteomics as an emerging weapon to develop new antibiotics against carbapenem resistant strain of Acinetobacter baumannii. J. Proteomics. 112, 336-338. doi: 10.1016/j.jprot.2014.09.008
88. Tognim, M. C., Gales, A. C., Penteado, A. P., Silbert, S., and Sader, H. S. (2006). Dissemination of IMP-1 metallo- beta -lactamase-producing Acinetobacter species in a Brazilian teaching hospital. Infect. Control Hosp. Epidemiol. 27, 742-747. doi: 10.1086/504356
89. Ultee, A., Bennik, M. H., and Moezelaar, R. (2002). The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl. Environ. Microbiol. 68, 1561-1568. doi: 10.1128/aem.68.4.1561-1568.2002
90. Valenzuela, J. K., Thomas, L., Partridge, S. R., van der Reijden, T., Dijkshoorn, L., and Iredell, J. (2007). Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J. Clin. Microbiol. 45, 453-460. doi: 10.1128/JCM.01971-06
91. Vashist, J., Tiwari, V., Kapil, A., and Rajeswari, M. R. (2010). Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii. J. Proteome Res. 9, 1121-1128. doi: 10.1021/pr9011188
92. Vila, J., Marti, S., and Sanchez-Cespedes, J. (2007). Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 59, 1210-1215. doi: 10.1093/jac/dkl509
93. Villas-Boas, S. G., Mas, S., Akesson, M., Smedsgaard, J., and Nielsen, J. (2005). Mass spectrometry in metabolome analysis. Mass Spectrom. Rev. 24, 613-646. doi: 10.1002/mas.20032
94. Villegas, M. V., Kattan, J. N., Correa, A., Lolans, K., Guzman, A. M., Woodford, N., et al (2007). Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals. Antimicrob. Agents Chemother. 51, 2001-2004. doi: 10.1128/AAC.00226-07
95. Wang, Y., Chang, L., Zhao, X., Meng, X., and Liu, Y. (2012). Gas chromatography-mass spectrometry analysis on compounds in volatile oils extracted from yuan zhi (Radix polygalae) and shi chang pu (Acorus tatarinowii) by supercritical CO2. J. Tradit. Chin. Med. 32, 459-464. doi: 10.1016/S0254-6272(13)60055-2
96. Wang, Y. F., and Dowzicky, M. J. (2010). In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Diagn. Microbiol. Infect. Dis. 68, 73-79. doi: 10.1016/j.diagmicrobio.2010.04.002
97. Weernink, A., Severin, W. P., Tjernberg, I., and Dijkshoorn, L. (1995). Pillows, an unexpected source of Acinetobacter. J. Hosp. Infect. 29, 189-199. doi: 10.1016/0195-6701(95)90328-3
98. Wilke, M. S., Lovering, A. L., and Strynadka, N. C. (2005). Beta-lactam antibiotic resistance: a current structural perspective. Curr. Opin. Microbiol. 8, 525-533. doi: 10.1016/j.mib.2005.08.016
99. Zarrilli, R., Giannouli, M., Tomasone, F., Triassi, M., and Tsakris, A. (2009). Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J. Infect. Dev. Ctries. 3, 335-341. doi: 10.3855/jidc.240
100. Zhao, W. H., Hu, Z. Q., Hara, Y., and Shimamura, T. (2002). Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus. Antimicrob. Agents Chemother. 46, 2266-2268. doi: 10.1128/AAC.46.7.2266-2268.2002